Extracted from this filing and checked against the source text.
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.99
MCKESSON CORP incurred credit facility of $750.0 million senior secured term A loan facility due 2031, $250.0 million senior secured term A loan facility due 2028 with JPMorgan Chase Bank, N.A., as administrative agent and collateral agent at Adjusted Term SOFR Rate plus applicable margin of 1.250% per annum or Base Rate maturing Term Loan A-1 Facility due 2031, Term Loan A-2 Facility due 2028, Revolving Credit Facility matures April 1, 2031.
- Instrument
- credit facility
- Principal
- $750.0 million senior secured term A loan facility due 2031, $250.0 million senior secured term A loan facility due 2028
- Counterparty
- JPMorgan Chase Bank, N.A., as administrative agent and collateral agent
- Rate
- Adjusted Term SOFR Rate plus applicable margin of 1.250% per annum or Base Rate
- Maturity
- Term Loan A-1 Facility due 2031, Term Loan A-2 Facility due 2028, Revolving Credit Facility matures April 1, 2031
- Event
- incurrence
Exact text from the filing
On April 1, 2026, certain of McKesson Corporation’s (the “Company”) subsidiaries, including McKesson Medical-Surgical Top Holdings, Inc. (the “Borrower”), entered into a credit agreement (the “Credit Agreement”) with the lenders and issuing banks party thereto and JPMorgan Chase Bank, N.A., as administrative agent and collateral agent providing for (i) a $750.0 million senior secured term “A” loan facility due 2031 (the “Term Loan A-1 Facility”), (ii) a $250.0 million senior secured term “A” loan facility due 2028 (the “Term Loan A-2 Facility” and, together with the Term Loan A-1 Facility, the “Term Loan A Facilities”) and (iii) a $1,000.0 million senior secured revolving credit facility (the “Revolving Credit Facility” and, together with the Term Loan A Facilities, the “Senior Secured Credit Facilities”).
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
MCKESSON CORP entered into Credit Agreement with JPMorgan Chase Bank, N.A., as administrative agent and collateral agent valued at $2,000.0 million (effective 2026-04-01).
- Action
- entry
- Agreement
- credit facility
- Counterparty
- JPMorgan Chase Bank, N.A., as administrative agent and collateral agent
- Value
- $2,000.0 million
- Effective
- 2026-04-01
Exact text from the filing
On April 1, 2026, certain of McKesson Corporation’s (the “Company”) subsidiaries, including McKesson Medical-Surgical Top Holdings, Inc. (the “Borrower”), entered into a credit agreement (the “Credit Agreement”) with the lenders and issuing banks party thereto and JPMorgan Chase Bank, N.A., as administrative agent and collateral agent providing for (i) a $750.0 million senior secured term “A” loan facility due 2031 (the “Term Loan A-1 Facility”), (ii) a $250.0 million senior secured term “A” loan facility due 2028 (the “Term Loan A-2 Facility” and, together with the Term Loan A-1 Facility, the “Term Loan A Facilities”) and (iii) a $1,000.0 million senior secured revolving credit facility (the “Revolving Credit Facility” and, together with the Term Loan A Facilities, the “Senior Secured Credit Facilities”).
View on SEC.gov